BACKGROUND: Experimental and epidemiologic data suggest that among nonpregnant adults, sleep duration may be an important risk factor for chronic disease. Although pregnant women commonly report poor sleep, few studies objectively evaluated the quality of sleep in pregnancy or explored the relationship between sleep disturbances and maternal and perinatal outcomes. OBJECTIVE: Our objective was to examine the relationship between objectively assessed sleep duration, timing, and continuity (measured via wrist actigraphy) and maternal cardiovascular and metabolic morbidity specific to pregnancy. STUDY DESIGN: This was a prospective cohort study of nulliparous women. Women were recruited between 16 0/7 and 21 6/7 weeks' gestation. They were asked to wear a wrist actigraphy monitor and complete a daily sleep log for a period of 7 consecutive days. The primary sleep exposure variables were the averages of the following over the total valid nights (minimum 5, maximum 7 nights): short sleep duration during the primary sleep period (<7 h/night), late sleep midpoint (midpoint between sleep onset and sleep offset >5 AM), and top quartile of minutes of wake time after sleep onset and sleep fragmentation index. The primary outcomes of interest were a composite of hypertensive disorders of pregnancy (mild, severe, or superimposed preeclampsia; eclampsia; or antepartum gestational hypertension) and gestational diabetes mellitus. We used c 2 tests to assess associations between sleep variables and categorical baseline characteristics. Crude odds ratios and 95% confidence intervals were estimated from univariate logistic regression models to characterize the magnitude of the relationship between sleep characteristics and hypertensive disorders of pregnancy and gestational diabetes. For associations significant in univariate analysis, multiple logistic regression was used to explore further the association of sleep characteristics with pregnancy outcomes. RESULTS: In all, 901 eligible women consented to participate; 782 submitted valid actigraphy studies. Short sleep duration and a later sleep midpoint were associated with an increased risk of gestational diabetes (odds ratio, 2.24; 95% confidence interval, 1.11e4.53; and odds ratio, 2.58; 95% confidence interval, 1.24e5.36, respectively) but not of hypertensive disorders. A model with both sleep duration and sleep midpoint as well as their interaction term revealed that while there was no significant interaction between these exposures, the main effects of both short sleep duration and later sleep midpoint with gestational diabetes remained significant (adjusted odds ratio, 2.06; 95% confidence interval, 1.01e4.19; and adjusted odds ratio, 2.37; 95% confidence interval, 1.13e4.97, respectively). Additionally, after adjusting separately for age, body mass index, and race/ethnicity, both short sleep duration and later sleep midpoint remained associated with gestational diabetes. No associations were demonstrated between the sleep quality measures (wake after sleep onset, sleep fragmentation) and hypertensive disorders or gestational diabetes. CONCLUSION: Our results demonstrate a relationship between short sleep duration and later sleep midpoint with gestational diabetes. Our data suggest independent contributions of these 2 sleep characteristics to the risk for gestational diabetes in nulliparous women.
Introduction
Experimental and epidemiologic data suggest that among nonpregnant adults, sleep duration is an important risk factor for chronic disease. [1] [2] [3] For example, short sleep duration has been linked to a higher frequency of hypertension and cardiovascular disease. [4] [5] [6] [7] There are particularly strong data suggesting that short sleep duration is associated with disordered metabolism and linked to an increase in the risk of type 2 diabetes. [8] [9] [10] Long sleep duration has also been linked to cardiovascular and metabolic disease. 5, 8 While considerable research has focused on sleep duration, other aspects of sleep, including the timing of sleep and wake cycles and continuity of sleep, have been proposed as potential cardiometabolic risk factors. [11] [12] [13] [14] Hypertensive disease (eg, preeclampsia) and metabolic disease (eg, gestational diabetes mellitus [GDM] ) also can be acute complications during pregnancy. Hypertensive disorders of pregnancy and GDM are associated with maternal and perinatal morbidity and have long-term health consequences for both mothers and babies. 15, 16 Nevertheless, although pregnant women commonly report poor sleep, 17 few studies objectively evaluated the duration, timing, and quality of sleep in Original Research ajog.org pregnancy and explored the relationship between objectively measured sleep and maternal and perinatal outcomes. [18] [19] [20] [21] [22] [23] [24] [25] Such a relationship is clinically relevant, as its existence may elucidate a modifiable factor for adverse pregnancy outcomes.
Therefore, our objective was to examine the relationship between objectively assessed sleep duration, timing, and continuity (measured via actigraphy) and maternal cardiovascular and metabolic morbidity specific to pregnancy.
Materials and Methods
This sleep duration and continuity study was conducted as a substudy of the Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-Be, an observational cohort study conducted at 8 clinical sites and managed by a central data-coordinating and analysis center. 26 The parent study protocol included nulliparous patients at least 13 years of age, although for this substudy, those age <18 years were excluded given significant differences in adolescent vs adult sleep. In addition, while the parent study included patients with chronic hypertension, they were excluded from this substudy given the difficulty in accurately diagnosing a new-onset hypertensive disorder in women with preexisting hypertension. Women with preexisting diabetes were also excluded as they cannot be diagnosed with GDM.
Women were recruited for this sleep substudy at the parent study's second study visit, which was scheduled between 16 0/7 and 21 6/7 weeks' gestation. They were asked to wear a wrist actigraphy monitor (Spectrum, Philips Respironics, Murrysville, PA) ( Figure) that records rest and activity periods and to complete a daily sleep log for the same 7 consecutive-day period. Subjects were given up to 23 0/7 weeks to complete the 7 days of actigraphy and sleep log data collection. For the sleep log, participants were asked to note bedtime, wake-up time, total sleep time, sleep latency, wake after sleep onset (WASO), naps, any unusual events during the sleep period, and overall sleep quality. Actigraphy provides an objective measure of rest-activity patterns from which various measures of sleep duration, quality, and timing can be determined daily. Studies have shown that there is good correlation between wrist actigraphy and polysomnographic recorded sleep. 27 In addition, actigraphy provides the ability to collect sleep-wake information over many consecutive days, unlike polysomnographic, in a simple, reliable, and cost-effective manner. Obtaining an objective evaluation of sleep is important because data suggest there is only a moderate correlation between selfreported and actigraphically recorded sleep, particularly among those with more disrupted sleep patterns. 28, 29 An actigraphy recording was considered successful if there was a minimum of 5 days recorded and if within the 5 days there was <4 hours of off-wrist time per 24-hour period and no offwrist signal during the time the subject indicated she was in bed. If a participant's recording did not meet these criteria, she was asked if she would be willing to wear the watch for another 7-day period if the total recording could be completed by 23 0/7 weeks.
All actigraph files and sleep log data were securely transmitted to a central actigraphy reading center. The complete sleep scoring and quality control protocol was described previously. 30 The primary sleep exposure variables for this analysis were the averages of the following over the total valid nights (minimum 5, maximum 7 nights): sleep duration during the primary sleep period, sleep midpoint (the midpoint between sleep onset and sleep offset), minutes of WASO, and sleep fragmentation index. These variables are defined in greater detail in Table 1 . Based on a review of available data detailing the relationship between sleep in nonpregnant populations and health outcomes, a cutoff of <7 hours for sleep duration was defined a priori as short sleep duration. 31 Similarly, a cutoff of >5 AM was defined a priori as a late sleep midpoint. 32, 33 As there are no well-established, clinically relevant cutoffs for actigraphy-defined WASO and sleep fragmentation, these continuous variables were transformed into quartiles; women were categorized based on these quartiles, with women in the quartiles representing the longest WASO and the greatest sleep fragmentation considered to have the most disturbed, poorest quality, sleep.
At least 30 days after delivery, a trained, certified chart abstractor assessed all participants' medical records to record birth outcomes and readmissions to the hospital. The primary outcomes of interest were: (1) a composite of hypertensive disorders of pregnancy (mild or severe preeclampsia; eclampsia; or antepartum gestational hypertension); and (2) GDM. For any participant with documented hypertension or proteinuria a detailed chart abstraction was performed that included assessment of blood pressure severity, new-onset neurologic disturbances, epigastric pain or pulmonary edema, and blood and urine laboratory results. The Supplement outlines study definitions for types of hypertensive disorders. Cases that presented atypically and were difficult to classify according to study criteria were adjudicated by review of clinical data by the principal investigators and final classification was reached by their consensus judgment.
All glucose tolerance testing (GTT) was performed as part of routine clinical care. A woman was considered to have GDM if she met 1 of the following GTT criteria: (1) fasting 3-hour 100-g GTT with 2 of the following values: fasting 95 mg/dL, 1-hour 180 mg/dL, Original Research OBSTETRICS ajog.org 2-hour 155 mg/dL, or 3-hour 140 mg/dL; (2) fasting 2-hour 75-g GTTwith 1 of the following values: fasting 92 mg/dL, 1-hour 180 mg/dL, or 2-hour 153 mg/dL; or (3) nonfasting 50-g GTT with a 1-hour value 200 mg/dL if no fasting 3-hour or 2-hour GTT was performed. In addition to GTT data, chart abstractors recorded if a diagnosis of GDM was made during the course of clinical care. If no GTT data were available, the diagnosis of GDM based on chart abstraction was used for GDM classification.
A detailed description of our sample size calculation was previously published. 30 In summary, assuming, as described in nonpregnant US populations, a short sleep duration prevalence of 25%, an outcome prevalence of at least 8% for pregnancy-related hypertension or GDM, and an a error of <5%, a sample size of 760 women would provide at least 80% power to detect a 2-fold increase in the risk of the adverse pregnancy outcomes among women with short sleep durations. 34 Descriptive statistics were used to characterize the study population by dichotomous sleep variables (sleep duration <7 hours, WASO 75th percentile, sleep fragmentation index 75th percentile, and sleep midpoint >5 AM). We used c 2 tests to assess the associations between sleep variables and categorical baseline characteristics. Kruskal-Wallis tests were used to compare the distribution of sleep variables for categories of baseline characteristics. Spearman correlation coefficients were used to assess relationships between sleep variables. Crude odds ratios (OR) and 95% confidence intervals (CI) were estimated from univariate logistic regression models to characterize the magnitude of the relationship between sleep characteristics and hypertensive disorders of pregnancy and GDM. For associations that were significant in univariate analysis, multiple logistic regression was used to explore further the association of sleep characteristics with pregnancy outcomes after adjustment for baseline characteristics. Adjustment covariates chosen a priori included maternal age and early pregnancy body mass index (BMI), treated as continuous variables and maternal race/ethnicity. Self-reported frequent snoring (a common symptom of sleep apnea), defined as prepregnancy snoring at least 3-4 times/wk, and employment schedule were also chosen as covariates given their association with our sleep variables and pregnancy outcomes. Linear and quadratic terms were included for age and BMI to help ensure that their relationships with the outcome were fully accounted for in the adjustment. Multiple logistic regression was also used post hoc to consider interactions between 2 sleep characteristics on pregnancy outcomes, and to assess their independent association with GDM. Initial models included main effects and interaction, but were reduced to main effects in the absence of a significant interaction.
All tests were performed at a nominal significance level of a ¼ 0.05 with 2-sided, single degree-of-freedom tests.
No correction was made for multiple comparisons. Analyses were conducted using software (SAS 9.3/9.4; SAS Institute Inc, Cary, NC). This study was approved by the institutional review board at each center, and all women provided informed written consent prior to enrollment.
Results
In all, 901 eligible women consented to participate. Of these, 782 submitted valid actigraphy studies and form the basis of this analysis. The median gestational age at recruitment (study visit 2) Sleep fragmentation, % Sleep FI is calculated as proportion of all epochs from sleep onset to sleep offset with activity count of 2 plus proportion of all bouts of immobility (activity count <2 in every epoch) that were 1 min in duration. FI was determined for each valid day then averaged for each available day (5e7 d).
Given that there are no well-established actigraphy-based cutoffs for FI, data were divided into quartiles and those with average FI 75th percentile were considered to have poor sleep. ajog.org The relationship between sleep metrics and hypertensive disorders of pregnancy and GDM are shown in Table 3 . Short sleep duration and a later sleep midpoint were associated with an increased risk of GDM (OR, 2.24; 95% CI, 1.11e4.53; and OR, 2.58; 95% CI, 1.24e5.36, respectively) but not hypertensive disorders. When we repeated the sleep duration and midpoint analyses excluding women whose GDM status was ascertained only through diagnosis from chart abstraction but without a documented GTT (N ¼ 44), the OR and P values did not change appreciably (data not shown). No associations were demonstrated between the sleep quality measures (WASO, sleep fragmentation) and hypertensive disorders or GDM.
Given the significant findings between both sleep duration and sleep midpoint in relation to GDM, we examined the relationship of sleep duration with sleep midpoint, and found they were not correlated in our cohort (Spearman (Table 4) . After adjusting for self-reported frequent snoring, sleep midpoint remained significantly associated with GDM; the magnitude of the effect of short sleep duration with GDM was similar to that seen in the other unadjusted and adjusted analyses, although the P value just exceeded .05 (aOR, 2.29; 95% CI, 0.97e5.39; P value ¼ .059).
Comment
Our data demonstrate that, among nulliparous women, both sleep duration and timing of sleep in the second trimester are associated with the development of GDM. Specifically, mean sleep duration of <7 hours per night was associated with an approximate 2-fold increase in the odds of GDM, and this association was independent of age, BMI, race/ethnicity, and self-reported frequent snoring. Similarly, a later sleep midpoint (>5 AM) was associated with an increased risk of GDM, and our data suggest that this increase was independent of sleep duration. We did not detect any relationship between measures of sleep duration, timing or sleep quality, and hypertensive disorders of pregnancy.
While laboratory studies demonstrate that experimentally fragmented sleep alters glucose metabolism, OR given to show association between gestational diabetes and sleep characteristic, without consideration of covariates and with separate adjustment for: age; BMI; race/ethnicity categories; white, non-Hispanic race/ethnicity; frequent snoring noted before pregnancy; and employment schedule (regular day shift, some form of shift work, unemployed). For race/ethnicity, Asian and other are collapsed.
BMI, body mass index; CI, confidence interval;
OR, odds ratio. ajog.org
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adrenocortical function, and sympathovagal balance, 11 in our study, sleep quality, as measured by WASO and sleep fragmentation, was not associated with maternal increased cardiovascular and metabolic morbidity. However, our negative results should be considered with caution. The degree of WASO disturbance and sleep fragmentation were categorized by quartiles as there are no other well-established, clinically relevant cutoffs for these sleep characteristics in pregnancy, and it is possible our sample size did not allow for the examination of more severe, but less common, phenotypes.
The major strengths of this study are the use of actigraphy to obtain a weeklong objective recording of rest/activity in coordination with a central and blinded actigraphy-reading center. The study population is diverse in terms of age, race, ethnicity, BMI, and socioeconomic measures, making our findings more generalizable. Nevertheless, given our onetime assessment of objectively measured sleep, we were not able to examine whether changes in sleep patterns and quality throughout pregnancy also may be associated with pregnancy outcomes. And while some studies suggest that long sleep duration (at least 9 hours) is also a risk factor for cardiovascular and metabolic disease, we were not able to examine the association between long sleep duration and hypertensive disorders and GDM due to the very small proportion of women who had sleep durations in this range (2.6%). Finally, given the observational design, there is always the possibility of residual confounding from unmeasured variables or a limit in the extent to which even measured confounders can be assessed.
In nonpregnant populations, several large, prospective cohort studies examined the association between sleep duration and incident type 2 diabetes, although the majority relied on selfreported sleep assessments. Most of these studies reported increased odds of diabetes associated with short sleep duration. In 2 independent pooled analyses of prospective studies, an association between short sleep and incident type 2 diabetes was documented, with OR 1.33 (95% CI, 1.20e1.48) and relative risk 1.28 (95% CI, 1.03e1.60) reported. 8, 9 Data from pregnancy cohorts, both prospective and retrospective, using self-reported sleep duration also suggested that short sleep is a risk factor for GDM. [35] [36] [37] In 1 study of 63 pregnant women who wore an actigraph in midpregnancy, objectively measured short sleep was associated with higher values on 1-hour GTTscreening. 21 Our data are consistent with and extend the findings of these previous reports, confirming that short sleep duration, as objectively measured by actigraphy, is associated with incident GDM in a large population of nulliparous women. Our study is the largest to date in which objective measures of sleep duration in pregnancy were obtained. Furthermore, by excluding women with pre-GDM, rigorously defining GDM, and measuring sleep duration <24 weeks, we optimized case ascertainment and ensured that our exposure variable predated the diagnosis in the vast majority of our subjects.
Compared to diabetes, the association between sleep duration and chronic hypertension is less consistent in nonpregnant individuals.
Crosssectional studies generally demonstrate a higher rate of hypertension among short sleepers, but data from longitudinal cohorts are conflicting. 38 Limited data on the association of sleep duration measures with hypertension in pregnancy are similarly conflicting. 20, 39 In our study of nulliparous women that excluded women with chronic hypertension, we failed to demonstrate a relationship between sleep duration and pregnancy-related hypertension. We were powered to detect an approximately 2-fold increase in risk, but cannot rule out the possibility of a more modest risk relationship.
In addition to sleep duration and continuity, the timing of sleep as a marker of circadian timing is emerging as a risk factor for cardiometabolic health. 32 Later sleep timing is often associated with circadian misalignment. This misalignment can occur when sleep and wakefulness behaviors do not occur at an appropriate time relative to the timing of the central circadian clock (hypothalamus) and/or relative to the external environment (light-dark cycle). A large survey study demonstrated that, when free from occupation and social obligations, the most commonly reported sleep timing is approximately midnight to 8:00 AM. 32 However, work and social demands as well as environmental influences can lead to alterations in sleep timing and circadian disruption. Experimental studies show that sleep misaligned with the timing of endogenous circadian rhythms is linked to alterations in leptin and glucose and increased mean arterial pressure. 40 In addition, being awake later at night has been linked to poorer health behaviors such as greater fast-food consumption and increased alcohol use. 12, 41 Epidemiologic data link shift work to an increased risk of obesity, type 2 diabetes, and cardiovascular disease. [42] [43] [44] Our study examined sleep timing in pregnancy (ie, sleep midpoint) as a risk factor for adverse pregnancy outcomes. We found that both having a shift-work schedule and being unemployed while pregnant were associated with a later sleep midpoint (>5 AM) and we demonstrated a strong association between later sleep timing and GDM that was independent of sleep duration and other confounders.
In conclusion, we found a relationship between short sleep duration and later sleep timing with GDM in nulliparous women. Our data suggest independent contributions of these 2 sleep characteristics to the risk for GDM. Identifying and addressing modifiable risks factors for GDM is important as GDM is associated with an increased risk of preeclampsia, fetal macrosomia, birth trauma, and neonatal metabolic complications. 45 Based on our data, sleep, like diet and exercise, should be considered a modifiable behavior that has potential health implications for pregnancy. Although this is an observational study, it is biologically plausible that the relationship may be causal. Yet, the mechanisms by which sleep duration and timing may impact metabolism in pregnancy are likely multifactorial and further research is needed to better (20 0 weeks of gestation through 14 days postpartum) for these new-onset maternal hypertensive disorders. In section A, the occurrence of new-onset hypertension (section A.1) plus 1 of the criteria marked with an "X" in section A.2 establishes the diagnosis of preeclampsia. Given a diagnosis of preeclampsia, the occurrence of any criterion marked with an "S" establishes the preeclampsia as severe; otherwise the diagnosis is mild preeclampsia. Note that some criteria, denoted with "X, S" have a dual role as indicators of preeclampsia and diagnostic criteria for severe preeclampsia.
EXHIBIT S1.1
Baseline hypertension and proteinuria
Chronic hypertension is: (1) a diagnosis of hypertension prior to pregnancy; or (2) hypertension (systolic blood pressure 140 mm Hg OR diastolic blood pressure 90 mm Hg on 2 occasions at least 6 hours apart or on 1 occasion followed by antihypertensive medication therapy) documented prior to pregnancy or <20 0 weeks' gestation.
Baseline proteinuria 300 mg/24 h. Total protein 300 mg in a 24-hour urine collection documented prior to pregnancy or <20 0 weeks' gestation. ajog.org
